Alterations in Proteolytic Activity at Low PH and Its Association with Invasion: a Theoretical Model
Overview
Authors
Affiliations
The extracellular pH (pHe) of solid tumours is often lower than in normal tissues, with median pH values of about 7.0 in tumours and 7.5 in normal tissue. Despite this more acidic tumour microenvironment, non-invasive measurements of intracellular pH (pHi) have shown that the pHi of solid tumours is neutral or slightly alkaline compared to normal tissue (pHi 7.0-7.4). This gives rise to a reversed cellular pH gradient between tumours and normal tissue, which has been implicated in many aspects of tumour progression. One such area is tumour invasion: the incubation of tumour cells at low pH has been shown to induce more aggressive invasive behaviour in vitro. In this paper the authors use mathematical models to investigate whether altered proteolytic activity at low pH is responsible for the stimulation of a more metastatic phenotype. The authors examined the effect of culture pH on the secretion and activity of two different classes of proteinases: the metalloproteinases (MMPs), and the cysteine proteinases (such as cathepsin B). The modelling suggests that changes in MMP activity at low pH do not have significant effects on invasive behaviour. However, the model predicts that the levels of active-cathepsin B are significantly altered by acidic pH. This result suggests a critical role for the cysteine proteinases in tumour progression.
Crossley R, Johnson S, Tsingos E, Bell Z, Berardi M, Botticelli M Front Cell Dev Biol. 2024; 12:1354132.
PMID: 38495620 PMC: 10940354. DOI: 10.3389/fcell.2024.1354132.
Koltai T Eur J Clin Nutr. 2020; 74(Suppl 1):14-19.
PMID: 32873952 DOI: 10.1038/s41430-020-0684-6.
Mix and Match: Phenotypic Coexistence as a Key Facilitator of Cancer Invasion.
Strobl M, Krause A, Damaghi M, Gillies R, Anderson A, Maini P Bull Math Biol. 2020; 82(1):15.
PMID: 31953602 PMC: 6968991. DOI: 10.1007/s11538-019-00675-0.
Maeda T, Suzuki A, Koga K, Miyamoto C, Maehata Y, Ozawa S Oncotarget. 2017; 8(45):78312-78326.
PMID: 29108231 PMC: 5667964. DOI: 10.18632/oncotarget.20826.
Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells.
Melzer C, von der Ohe J, Lehnert H, Ungefroren H, Hass R Mol Cancer. 2017; 16(1):28.
PMID: 28148265 PMC: 5286787. DOI: 10.1186/s12943-017-0595-x.